Recruiting Diabetic Retinopathy Studies in Palo Alto
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Typ...
About Diabetic Retinopathy Clinical Trials in Palo Alto
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 2 diabetic retinopathy clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 278 participants. Research is being sponsored by Boehringer Ingelheim, Vantage Biosciences Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Palo Alto — FAQ
Are there diabetic retinopathy clinical trials in Palo Alto?
Yes, there are 2 diabetic retinopathy clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated March 2, 2026 from ClinicalTrials.gov